J0717 — Certolizumab Pegol Inj 1mg
$18,825
All-payer median here
$20,917
Cash / self-pay here
18
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.